ANGELA RAY: Open Payments
NPI 1437861861 · MURRAY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,476 in 84 payments from 14 companies in 2025. Trend: 2023 $989 · 2024 $1,549 · 2025 $1,476
Food & beverage: $1,425Education: $51
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $296 |
| Phathom Pharmaceuticals, Inc. | 16 | $178 |
| Madrigal Pharmaceuticals | 9 | $157 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $148 |
| PFIZER INC. | 6 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $101 |
| Aimmune Therapeutics, Inc. | 4 | $92 |
| Ardelyx, Inc. | 3 | $79 |
| Mirum Pharmaceuticals, Inc. | 3 | $69 |
| ABBVIE INC. | 4 | $67 |
Products named: TREMFYA, VOQUEZNA, REZDIFFRA, XIFAXAN, XELJANZ, ENTYVIO, IBSRELA, Livmarli.
Industry payments across KY — which companies pay providers there.
